Results 121 to 130 of about 5,674 (178)

Repurposing antiviral agents against mucormycosis. [PDF]

PLoS One
Khan AA, AlKashef NM, Seleem MN.
europepmc   +1 more source

High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in Vietnam. [PDF]

J Viral Hepat
Laureillard D, Binh NT, Vinh VH, Hong TT, Quillet C, Thanh NTT, Vallo R, Quynh BTN, Moles JP, Oanh KTH, Huong DT, Rapoud D, Feelemyer J, Michel L, Vickerman P, Fraser H, Weiss L, Lemoine M, Lacombe K, Jarlais DD, Khue PM, Nagot N.   +21 more
europepmc   +1 more source

Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trial. [PDF]

Lancet
Cooke GS, Hung LM, Flower B, McCabe L, Hang VTK, Thu VT, Thuan DT, Dung NT, Phuong LT, Khoa DB, An NTC, Thach PN, Huong VTT, Bich DT, Tuyen NK, Ansari MA, Le Ngoc C, Quang VM, Phuong NTN, Thao LT, Tran NB, Kestelyn E, Kingsley C, Van Doorn R, Rahman M, Pett SL, Thwaites GE, Barnes E, Day JN, Chau NVV, Walker AS.   +30 more
europepmc   +1 more source

Activated Sludge in the Bioremediation of Water Containing SARS-CoV-2 Antivirals. [PDF]

J Xenobiot
Lastovčić D, Zirn I, Jezerčić T, Bule Možar K, Večenaj L, Cvetnić M, Ujević Bošnjak M, Markić M, Bolanča T, Ukić Š, Kučić Grgić D.   +10 more
europepmc   +1 more source

Chronic blood-borne viral hepatitis in a tertiary hospital in Al-Baha, Saudi Arabia: epidemiology, liver enzyme correlations, and treatment outcomes. [PDF]

BMC Infect Dis
Sallam TA, El-Badry RM, Alkully TH, Alfahemi HH, Halwani MA, Alzahrani KI, Alghamdi MA.   +6 more
europepmc   +1 more source

Single-cell analysis of heterogeneity in reverted hiPSC-derived human hepatic stellate cells. [PDF]

JHEP Rep
Wang X, Ha EH, Bian L, Feng Z, Zhang F, O'Shaughnessy K, Wang L, Hochwald A, Zheng Y, Chen W, Zhang Y, Wu X.   +11 more
europepmc   +1 more source

Economic evaluation of alternative hepatitis C treatment options: a post hoc analysis of the VIETNARMS trial. [PDF]

EClinicalMedicine
Turner HC, Ahmed S, Nguyen HA, Hung LM, Van Nuil J, Thuan DT, SEARCH investigators, Dung NT, Thwaites GE, Walker AS, Chau NVV, Cooke GS, Hallett TB.   +12 more
europepmc   +1 more source

Machine learning-based prediction of treatment response in comorbid hepatitis C patients receiving DAA therapy: a real-world study from Pakistan. [PDF]

Front Public Health
Nishwa DE, Abbas Z, Lee SW.
europepmc   +1 more source

Budget impact analysis of glecaprevir/pibrentasvir treatment for hepatitis C in Iran: a modelling study. [PDF]

BMJ Open
Jafari M, Mehdizadeh P, Keshavarz K, Teymourzadeh E, Abyazi MA, Gholamreza Shirazi P.   +5 more
europepmc   +1 more source

Challenges in the Diagnosis of Autoimmune Hepatitis in Patients With Chronic Viral Hepatitis C: A Case Series and Review of the Literature. [PDF]

Cureus
Malakar S, Kumar S, Jangra R, Agarwal M, Parwar A, Kohli KP, Mishra S, Bhardwaj A, Kumar A, Singh A, Yadav DK, Tiwari A, Gandhi A, Shukla G, Rungta S.   +14 more
europepmc   +1 more source